Alper Türkel

7PUBLICATIONS
25CO-AUTHORS
Predictive and prognostic markersMidwifery not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 28, 2026
Prognostic Significance of the CPS-EG Score in Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy.

|Oct 24, 2025
Investigation of the prevalence of HER2-ultralow and the effects of HER2 status (HER2-null vs. HER2-ultralow) on survival in HER2-negative early-stage breast cancer.

Alper Türkel, Sultan Çiğdem Irkkan, İlknur Deliktaş Onur

|Nov 26, 2024
Evaluation of CDK4/6 inhibitors in first-line in symptomatic and asymptomatic patients with metastatic breast cancer.

İrem Öner, Alper Türkel, Hicran Anık

|Aug 29, 2024
Effects of BRCA variation on prognosis in patients with nonmetastatic breast cancer.

Alper Türkel, Ilknur Deliktaş Onur, Hicran Anik

|Jun 13, 2023
Gemcitabine-associated digital necrosis in metastatic breast cancer.

Alper Türkel, Mustafa Özdemir, Aziz Kurtuluş

|Feb 10, 2023
Vitiligo-like lesions associated with ribociclib in a woman with metastatic breast cancer.

Alper Türkel, Cengiz Karaçin, İrem Öner

Pageof 2

Frequent Collaborators

4 joint publications

Cengiz Karaçin

1 joint publications

Öztürk Ateş

1 joint publications

Mutlu Doğan

1 joint publications

İrem Öner